Arch Capital Group Ltd. to Report 2020 Fourth Quarter Results on February 9, 2021 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags conferences earnings 01/08/2021 - 09:00 AM Arch Capital Group Ltd. [NASDAQ: ACGL] an
$ELAB Top Gainer NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments Mar 27, 2026 +98.44%
$ARTL Top Loser Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules Mar 27, 2026 -21.92% private placement
$ACGL Same Company Arch Capital Group Ltd. to Report 2026 First Quarter Results on April 28 Mar 17, 2026 earnings date
$RA Related Brookfield Real Assets Income Fund Inc. Declares Q2 2026 Distribution Schedule Mar 27, 2026
$MAIN Related Main Street Prices Public Offering of $200,000,000 Million of 6.95% Notes due 2029 Mar 27, 2026 offering
$MLTX Related MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting Mar 28, 2026 clinical trial
$LLY Related Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity Mar 28, 2026